MEDICAL BIO WARFARE DEFENSE PLAN 18 MAR 91

File: 970107_sep96_decls57_0009.txt
Page: 0009
Total Pages: 10

Subject: MEDICAL BIO WARFARE DEFENSE PLAN  18 MAR 91                     

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003202

Folder Title: MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN                                                   

Document Number:          1

Folder Seq  #:         25



                                      UNCLASSIFIED





          Venezuelan Equine Encephalitis) will be stockpiled based on force
          strength data in para la. Vaccinia Immune Globulin used to counter
          adverse effects of smallpox vaccination will also be stockpiled.

             c.  @ Anthrax and botulinum vaccine and antitoxin
          requirements (doses):

                             Anthrax     Botulinum    Botulinum
                             Vaccine      Vaccine     Antitoxin

                 Army
                 Air Force
                 Navy         TBD          TBD          TBD

          2. (U) Establish the Joint Medical Biological Warfare Defense
          Committee (,TMBWDC) to make decisions on vaccination of U.S. Forces
          against BW agents. Army membership will include representatives
          from DCSOPS, OTSG, and DCSINT. Other services should have
          representatives from similar functional areas. Executive Agent
          will be Army. objective is to address Medical BW Defense as a
          normal course of readiness and preparation of the force for war.

          3. (U) Immunize the services' designated early deploying forces
          during peacetime against specific Bw agents to maximize readiness
          and deployment posture. Amend the Tri-Service regulation AR
          40-526/NAVMEDCOMINST 6230.3/AFR 161-13/CG COMDTINST M6230.4D,
          Immunizations and Chemoprophylaxis, to reflect this.

          4. @ Decentralize storage of vaccines for security purposes.
             a. 1% Portion of the vaccines and antitoxin will be stored
          with the manufacturer such as Michigan Department of Public Health
          (anthrax and botulinum vaccine), University of Minnesota (botulinum
          antitoxin), Winthrop Laboratory (smallpox), and the Salk Institute
          (tularemia and Venezuelan Equine Encephalitis). Certain number of
          doses will be kept in multi-dose vials at all times for contingency
          use.

 b.      Remaining vaccines and antitoxin will be stored at the
          National Center for Toxicological Research (NCTR) in Jefferson,
          AR. NCTR vaccine storage facility should be operational in
          2QFY92. Effort was started in FY90 by OTSG.

          5. (U) Store vaccines and antitoxins in bulk to maximize
          shelf-life to greater than ten years. Vaccines and antitoxins
          stored in bulk are tested annually for potency. As long as they
          pass the potency tests, they are considered usable by the Food and
          Drug Administration. Once these products are packaged in
          multi-dose vials, they normally have a two to three year
          shelf-life. The shelf-life of these products may be extended but



                                                  UNCLASSIFIED


                                            2

Document 10 f:/Week-36/BX003202/MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN/medical bio warfare defense plan 18 mar 91:01029715474558
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN
Folder Seq # = 25
Subject = MEDICAL BIO WARFARE DEFENSE PLAN 18 MAR 91
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997